Boudousquié, C.; Boand, V.; Lingre, E.; Dutoit, L.; Balint, K.; Danilo, M.; Harari, A.; Gannon, P.O.; Kandalaft, L.E.
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine. Vaccines 2020, 8, 25.
https://doi.org/10.3390/vaccines8010025
AMA Style
Boudousquié C, Boand V, Lingre E, Dutoit L, Balint K, Danilo M, Harari A, Gannon PO, Kandalaft LE.
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine. Vaccines. 2020; 8(1):25.
https://doi.org/10.3390/vaccines8010025
Chicago/Turabian Style
Boudousquié, Caroline, Valérie Boand, Emilie Lingre, Laeticia Dutoit, Klara Balint, Maxime Danilo, Alexandre Harari, Philippe O. Gannon, and Lana E. Kandalaft.
2020. "Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine" Vaccines 8, no. 1: 25.
https://doi.org/10.3390/vaccines8010025
APA Style
Boudousquié, C., Boand, V., Lingre, E., Dutoit, L., Balint, K., Danilo, M., Harari, A., Gannon, P. O., & Kandalaft, L. E.
(2020). Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine. Vaccines, 8(1), 25.
https://doi.org/10.3390/vaccines8010025